◆ 会议时间：2025年9月12-13日
◆ 会议地点：秘鲁 利马

◆ 会议简介：

2025年第9届世界乳腺癌争议大会(CoBrCa)将于2025年9月12-13日在秘鲁利马举行。本次CoBrCa大会将继续直接处理临床医生在日常实践中面临的关键和有争议的问题，努力找到解决未解决的临床和治疗问题宣的办法。专家们将围绕肿瘤学、外科学、乳腺成像、放射肿瘤学、病理学、重建等主题进行辩论、讨论和演讲。每次讲座结束时，听众将有充足的时间参与讨论。未经许可禁止复制转载摘录镜像本站任何内容-国际医学会议网(lingyuint.com)。

9th World Congress on Controversies in Breast Cancer (CoBrCa2025)

Date:
September 12-13, 2025

Venue:
JW Marriott Hotel Lima
Lima, Peru

摘要征文投稿：

Abstract submission deadline: Monday, June 16, 2025

点此提交摘要>>>Submit Abstract>>>

Abstract Guidelines

• Abstracts can be submitted online only. Abstracts submitted via email will not be accepted.
• All abstracts must be submitted and presented in English.
• The abstract title is limited to 27 words and should be in CAPS.
• The abstract body may not be longer than 350 words.
• Authors are limited to 15 per abstract.
• Abstracts may include a maximum of one image per abstract (graph/photo) in JPEG format only.
• The text must be formatted in Ariel font size 10. Only the title, abbreviations and acronyms should be in ALL CAPS.
• Abbreviations should be defined.
  
• Please write concisely and clearly and structure your abstract with the headings:
  Problem statement
  Methods
  Results
  Conclusion
  
• Please ensure that your abstract does not contain spelling, grammar or scientific errors, as it will be reproduced exactly as submitted. No proofreading will be done. Linguistic accuracy is the responsibility of the submitter.
• Abstract submissions that do not meet the above noted guidelines may be rejected without review.
  
• Please include Disclosure of Interest, if any, at the end of the abstract body.
  
• The Organizing Committee may request additional information about abstracts.

Welcome Letter

We are delighted to announce the exciting joint venture between the World Congress on Controversies in Breast Cancer (CoBrCa) and leading Peruvian medical societies which brings about the 9th CoBrCa Congress to take place at the JW Marriott Hotel in Lima, Peru from September 12-13, 2025. This collaboration marks a significant milestone in bringing together international expertise and local knowledge to address the most pressing challenges in breast cancer.

The CoBrCa Congress, renowned for its excellence in addressing current clinical controversies in a multidisciplinary manner, will be partnered with Peru’s leading organisations in breast cancer care, creating a unique opportunity for professionals from across the globe and Latin America to come together. This synergy promises to foster exchange of knowledge, provide valuable networking opportunities, and enhance the global perspective on the latest advances in breast cancer treatment and research.

The joint venture will not only enrich the congress experience but also contribute to the strengthening of Peru’s medical community, promoting local expertise on an international platform. Through debates, panel discussions and didactic talks, participants will engage in meaningful dialogue and collaboration, empowering healthcare professionals across all levels to improve patient outcomes.

We look forward to welcoming you to CoBrCa 2025 in Lima, Peru.

CoBrCa 2025 Organizing Committee

Chairpersons

Luis Pinillos Ashton
Peru

Henry Gomez Moreno
Peru

Mauricio León Rivera
Peru

CoBrCa Chairpersons

Javier Cortes
Spain

Richard De Boer
Australia

Bruce Mann
Australia

Alastair Thompson
USA

注册费：

Register for the CoBrCa congress

Fees

Fees include: CoBrCa Congress scientific updates, newsletters, access to accepted abstracts, participation in the Congress, participation in the best poster competition, the CoBrCa Congress e-Book, Congress material, CoBrCa Congress certificate, free access to CoBrCa Congress Networking Reception and catering during official congress breaks (coffee/tea and lunch) as indicated in the congress program. 

*Nurses, Students, Registrars, Residents, Fellows and Allied Health Professionals must provide proof confirming their status, which can be sent by replying to the registration confirmation email you will receive upon completion of the process.

◆ 参会对象：
妇科医生，肿瘤科医生，外科医生，护士，病理学家，放射科医生，临床医生，住院医师，放射肿瘤学家，学生，以及其他相关卫生保健专业人士。